| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 9.41e-12 | 26 | 146 | 8 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.86e-09 | 52 | 146 | 8 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium ion binding | 3.70e-08 | 14 | 146 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN1A SCN2A SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A SLC29A1 | 5.30e-08 | 171 | 146 | 11 | GO:0015081 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 DNAH3 DNAH10 COQ8B ATP10B RFC5 HELQ ATP10A ATP10D DHX15 ATP6V1H ATP12A DNAH9 DYNC1H1 AQR DNAH11 | 1.54e-07 | 441 | 146 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.55e-07 | 18 | 146 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A GABRG1 GABRG3 ABCC3 ATP6V1H CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A ANO3 SLC29A1 GABRA2 | 1.55e-07 | 758 | 146 | 21 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A GABRG1 GABRG3 CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 GABRA2 | 2.63e-07 | 459 | 146 | 16 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | CACNA1A GABRG1 GABRG3 MPEG1 CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 GABRA2 | 3.08e-07 | 525 | 146 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A GABRG1 GABRG3 MPEG1 CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ANO3 GABRA2 | 3.16e-07 | 526 | 146 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | glycosylceramide flippase activity | 3.83e-07 | 3 | 146 | 3 | GO:0140351 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A GABRG1 GABRG3 ABCC3 SLC6A16 SPNS2 MPEG1 ATP10B ATP10A ATP10D ATP6V1H CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A ANO3 SLC29A1 GABRA2 | 6.30e-07 | 1289 | 146 | 27 | GO:0005215 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.13e-06 | 26 | 146 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A GABRG1 GABRG3 ATP6V1H CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A ANO3 SLC29A1 GABRA2 | 1.37e-06 | 793 | 146 | 20 | GO:0015075 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.67e-06 | 28 | 146 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A GABRG1 GABRG3 ABCC3 SLC6A16 SPNS2 MPEG1 ATP6V1H CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A ANO3 SLC29A1 GABRA2 | 4.82e-06 | 1180 | 146 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 7.04e-06 | 37 | 146 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A SLC29A1 | 8.31e-06 | 465 | 146 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 DNAH3 DNAH10 COQ8B ATP10B RFC5 HELQ ATP10A ATP10D DHX15 ATP6V1H ATP12A DNAH9 DYNC1H1 AQR DNAH11 | 1.13e-05 | 614 | 146 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.21e-05 | 20 | 146 | 4 | GO:0046624 | |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1A GABRG1 GABRG3 CLCN7 KCNJ5 SCN1A SCN2A SCN7A SCN10A ANO3 GABRA2 | 3.58e-05 | 334 | 146 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 4.55e-05 | 343 | 146 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A ATP6V1H KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A SLC29A1 | 5.73e-05 | 627 | 146 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 6.05e-05 | 11 | 146 | 3 | GO:0008503 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A ATP6V1H KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A SLC29A1 | 1.09e-04 | 664 | 146 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 DNAH3 DNAH10 COQ8B ATP10B RFC5 HELQ ATP10A ATP10D DHX15 ATP6V1H ASMTL ATP12A DNAH9 DYNC1H1 AQR DNAH11 | 1.39e-04 | 839 | 146 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 DNAH3 DNAH10 COQ8B ATP10B RFC5 HELQ ATP10A ATP10D DHX15 ATP6V1H ASMTL ATP12A DNAH9 DYNC1H1 AQR DNAH11 | 1.41e-04 | 840 | 146 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 DNAH3 DNAH10 COQ8B ATP10B RFC5 HELQ ATP10A ATP10D DHX15 ATP6V1H ASMTL ATP12A DNAH9 DYNC1H1 AQR DNAH11 | 1.41e-04 | 840 | 146 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.61e-04 | 70 | 146 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 DNAH3 DNAH10 COQ8B ATP10B RFC5 HELQ ATP10A ATP10D DHX15 ATP6V1H ATP12A DNAH9 DYNC1H1 AQR DNAH11 | 1.79e-04 | 775 | 146 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.42e-04 | 17 | 146 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | flippase activity | 2.42e-04 | 17 | 146 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 2.88e-04 | 18 | 146 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 3.41e-04 | 19 | 146 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | chloride channel activity | 4.22e-04 | 86 | 146 | 5 | GO:0005254 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 4.86e-04 | 50 | 146 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 5.25e-04 | 51 | 146 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 5.33e-04 | 22 | 146 | 3 | GO:0016864 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 5.33e-04 | 22 | 146 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 5.33e-04 | 22 | 146 | 3 | GO:0003756 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 7.81e-04 | 6 | 146 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 9.61e-04 | 103 | 146 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.10e-03 | 28 | 146 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.63e-03 | 171 | 146 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.76e-03 | 118 | 146 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRG1 GABRG3 LPAR3 GPER1 VN1R17P OR1A2 RET GRM3 AR ADGRG4 PROKR2 OR13A1 SCN7A OR1P1 TACR2 ADGRF3 TAS2R19 PLXNA1 GABRA2 EPHA8 | 2.04e-03 | 1353 | 146 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.23e-03 | 182 | 146 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.27e-03 | 125 | 146 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.36e-03 | 184 | 146 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.23e-03 | 196 | 146 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 4.56e-03 | 14 | 146 | 2 | GO:0140333 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 4.54e-10 | 62 | 144 | 9 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 5.26e-10 | 63 | 144 | 9 | GO:0019228 | |
| GeneOntologyBiologicalProcess | regulation of brain-derived neurotrophic factor-activated receptor activity | 2.28e-09 | 4 | 144 | 4 | GO:0031551 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.92e-09 | 36 | 144 | 7 | GO:0086010 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | CACNA1A NPR2 GPER1 SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A SCN10A | 6.19e-09 | 112 | 144 | 10 | GO:0019226 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 9.90e-09 | 87 | 144 | 9 | GO:0086001 | |
| GeneOntologyBiologicalProcess | negative regulation of brain-derived neurotrophic factor receptor signaling pathway | 1.13e-08 | 5 | 144 | 4 | GO:0031549 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1A GABRG1 GABRG3 NPR2 GPER1 NLGN4X KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A FOXP1 IGSF9B SLC29A1 GABRA2 | 1.30e-08 | 559 | 144 | 19 | GO:0042391 |
| GeneOntologyBiologicalProcess | action potential | NPR2 GPER1 KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A FOXP1 | 1.78e-08 | 201 | 144 | 12 | GO:0001508 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.79e-08 | 93 | 144 | 9 | GO:0086003 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATG5 CACNA1A GABRG1 GABRG3 ABCC3 LPAR3 GPER1 SLC6A16 ATP10A ATP10D TMX1 ATP6V1H CLCN7 RAPGEF3 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A TACR2 HEPHL1 ATP12A ANO3 GABRA2 | 1.86e-08 | 1374 | 144 | 30 | GO:0006811 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A MYBPC3 | 2.09e-08 | 127 | 144 | 10 | GO:0070252 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATG5 CACNA1A GABRG1 GABRG3 ABCC3 GPER1 SLC6A16 ATP10A ATP10D ATP6V1H CLCN7 RAPGEF3 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A ANO3 GABRA2 | 5.38e-08 | 1115 | 144 | 26 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of brain-derived neurotrophic factor receptor signaling pathway | 7.85e-08 | 7 | 144 | 4 | GO:0031548 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A MYBPC3 | 1.23e-07 | 153 | 144 | 10 | GO:0030048 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC6A16 SCN1A SCN2A SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A | 2.44e-07 | 208 | 144 | 11 | GO:0035725 |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A MYBPC3 | 2.79e-07 | 167 | 144 | 10 | GO:0060048 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATG5 CACNA1A GABRG1 GABRG3 GPER1 SLC6A16 ATP6V1H CLCN7 RAPGEF3 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A ANO3 GABRA2 | 5.99e-07 | 1017 | 144 | 23 | GO:0098660 |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.15e-06 | 121 | 144 | 8 | GO:0051899 | |
| GeneOntologyBiologicalProcess | brain-derived neurotrophic factor receptor signaling pathway | 2.16e-06 | 14 | 144 | 4 | GO:0031547 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A MYBPC3 | 3.04e-06 | 217 | 144 | 10 | GO:0006941 |
| GeneOntologyBiologicalProcess | circulatory system process | ATG5 ABCC3 NPR2 GPER1 AR KCNJ5 SCN1A SCN2A SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A TACR2 SLC29A1 MYBPC3 | 3.68e-06 | 733 | 144 | 18 | GO:0003013 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC6A16 SCN1A SCN2A SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A | 3.78e-06 | 275 | 144 | 11 | GO:0006814 |
| GeneOntologyBiologicalProcess | heart contraction | ATG5 KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A MYBPC3 | 8.12e-06 | 298 | 144 | 11 | GO:0060047 |
| GeneOntologyBiologicalProcess | heart process | ATG5 KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A MYBPC3 | 1.14e-05 | 309 | 144 | 11 | GO:0003015 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATG5 CACNA1A LPAR3 GPER1 SLC6A16 ATP10D TMX1 ATP6V1H RAPGEF3 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A HEPHL1 ATP12A | 1.74e-05 | 1157 | 144 | 22 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | ATG5 CACNA1A LPAR3 GPER1 SLC6A16 TMX1 RAPGEF3 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A HEPHL1 ATP12A | 2.14e-05 | 1000 | 144 | 20 | GO:0030001 |
| GeneOntologyBiologicalProcess | muscle contraction | GPER1 KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A TACR2 MYBPC3 | 2.49e-05 | 400 | 144 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | response to pain | 2.81e-05 | 51 | 144 | 5 | GO:0048265 | |
| GeneOntologyBiologicalProcess | muscle system process | GPER1 AR KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A FOXP1 TACR2 MYBPC3 | 3.02e-05 | 547 | 144 | 14 | GO:0003012 |
| GeneOntologyBiologicalProcess | negative regulation of lung goblet cell differentiation | 4.84e-05 | 2 | 144 | 2 | GO:1901250 | |
| GeneOntologyBiologicalProcess | blood circulation | ATG5 NPR2 GPER1 AR KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A TACR2 MYBPC3 | 4.93e-05 | 648 | 144 | 15 | GO:0008015 |
| GeneOntologyBiologicalProcess | negative regulation of protein tyrosine kinase activity | 5.42e-05 | 30 | 144 | 4 | GO:0061099 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 7.04e-05 | 32 | 144 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATG5 CACNA1A GPER1 SLC6A16 ATP6V1H RAPGEF3 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A | 7.78e-05 | 922 | 144 | 18 | GO:0098662 |
| GeneOntologyBiologicalProcess | negative regulation of signaling receptor activity | 7.97e-05 | 33 | 144 | 4 | GO:2000272 | |
| GeneOntologyBiologicalProcess | mucociliary clearance | 9.05e-05 | 13 | 144 | 3 | GO:0120197 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 1.01e-04 | 35 | 144 | 4 | GO:0007214 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATG5 CACNA1A GPER1 SLC6A16 ATP6V1H RAPGEF3 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SLC6A20 SCN7A SCN8A SCN9A SCN10A ATP12A | 1.02e-04 | 942 | 144 | 18 | GO:0098655 |
| GeneOntologyBiologicalProcess | nerve development | 1.17e-04 | 109 | 144 | 6 | GO:0021675 | |
| GeneOntologyBiologicalProcess | regulation of lung goblet cell differentiation | 1.45e-04 | 3 | 144 | 2 | GO:1901249 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 2.58e-04 | 126 | 144 | 6 | GO:0033555 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 2.73e-04 | 238 | 144 | 8 | GO:0050954 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 2.88e-04 | 4 | 144 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | positive regulation of collagen fibril organization | 2.88e-04 | 4 | 144 | 2 | GO:1904028 | |
| GeneOntologyBiologicalProcess | adult walking behavior | 4.09e-04 | 50 | 144 | 4 | GO:0007628 | |
| GeneOntologyBiologicalProcess | cilium movement | 5.05e-04 | 261 | 144 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 5.89e-04 | 55 | 144 | 4 | GO:0045332 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer morphogenesis | 6.85e-04 | 25 | 144 | 3 | GO:0021692 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 6.95e-04 | 210 | 144 | 7 | GO:0060294 | |
| GeneOntologyBiologicalProcess | lung goblet cell differentiation | 7.13e-04 | 6 | 144 | 2 | GO:0060480 | |
| GeneOntologyBiologicalProcess | rhythmic synaptic transmission | 7.13e-04 | 6 | 144 | 2 | GO:0060024 | |
| GeneOntologyBiologicalProcess | protein lipidation | 7.16e-04 | 101 | 144 | 5 | GO:0006497 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 7.26e-04 | 153 | 144 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-tyrosine phosphorylation | 7.70e-04 | 59 | 144 | 4 | GO:0050732 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 7.70e-04 | 59 | 144 | 4 | GO:0003351 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 7.98e-04 | 215 | 144 | 7 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 7.98e-04 | 215 | 144 | 7 | GO:0001539 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | ATG5 CACNA1A GABRG1 GABRG3 LPAR3 NPR2 PDE4A GPER1 CHAT GRM3 NLGN4X TACR2 IGSF9B FER1L5 SLC29A1 GABRA2 | 8.04e-04 | 931 | 144 | 16 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | ATG5 CACNA1A GABRG1 GABRG3 LPAR3 NPR2 PDE4A GPER1 CHAT GRM3 NLGN4X TACR2 IGSF9B FER1L5 SLC29A1 GABRA2 | 8.04e-04 | 931 | 144 | 16 | GO:0007268 |
| GeneOntologyBiologicalProcess | lipid translocation | 8.20e-04 | 60 | 144 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | walking behavior | 8.20e-04 | 60 | 144 | 4 | GO:0090659 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | ATG5 CACNA1A GABRG1 GABRG3 LPAR3 NPR2 PDE4A GPER1 CHAT GRM3 NLGN4X TACR2 IGSF9B FER1L5 SLC29A1 GABRA2 | 8.80e-04 | 939 | 144 | 16 | GO:0099537 |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | 8.81e-04 | 429 | 144 | 10 | GO:0046486 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 8.91e-04 | 106 | 144 | 5 | GO:0042158 | |
| GeneOntologyBiologicalProcess | extracellular transport | 9.28e-04 | 62 | 144 | 4 | GO:0006858 | |
| GeneOntologyBiologicalProcess | courtship behavior | 9.93e-04 | 7 | 144 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | regulation of acetylcholine secretion, neurotransmission | 9.93e-04 | 7 | 144 | 2 | GO:0014056 | |
| GeneOntologyBiologicalProcess | acetylcholine secretion, neurotransmission | 9.93e-04 | 7 | 144 | 2 | GO:0014055 | |
| GeneOntologyBiologicalProcess | lobar bronchus epithelium development | 9.93e-04 | 7 | 144 | 2 | GO:0060481 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.11e-03 | 65 | 144 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.14e-03 | 112 | 144 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 1.18e-03 | 30 | 144 | 3 | GO:1904862 | |
| GeneOntologyBiologicalProcess | synaptic signaling | ATG5 CACNA1A GABRG1 GABRG3 LPAR3 NPR2 PDE4A GPER1 CHAT GRM3 NLGN4X TACR2 IGSF9B FER1L5 SLC29A1 GABRA2 | 1.32e-03 | 976 | 144 | 16 | GO:0099536 |
| GeneOntologyBiologicalProcess | acetylcholine secretion | 1.32e-03 | 8 | 144 | 2 | GO:0061526 | |
| GeneOntologyBiologicalProcess | lobar bronchus development | 1.32e-03 | 8 | 144 | 2 | GO:0060482 | |
| GeneOntologyBiologicalProcess | sensory perception | NPR2 PDE4A SPNS2 VN1R17P OR1A2 TECTA CHM GRM3 SCN1A B3GNT2 PGAP1 OR13A1 SCN8A SCN9A SCN10A OR1P1 TAS2R19 | 1.33e-03 | 1072 | 144 | 17 | GO:0007600 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.20e-13 | 17 | 148 | 8 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.97e-11 | 29 | 148 | 8 | GO:0034706 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1A GABRG1 GABRG3 ATP10B ATP10A ATP10D ATP6V1H CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ATP12A GABRA2 | 2.15e-09 | 550 | 148 | 20 | GO:1990351 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1A GABRG1 GABRG3 CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A GABRA2 | 8.14e-08 | 378 | 148 | 15 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1A GABRG1 GABRG3 ATP6V1H CLCN7 KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ATP12A GABRA2 | 1.88e-07 | 523 | 148 | 17 | GO:1902495 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1A KCNJ5 SCN1A SCN2A MCU SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 9.49e-07 | 235 | 148 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | axon | ATG5 EXOC6 FKBP15 LPAR3 GPER1 SMURF1 CHAT RET GRM3 AR RAPGEF3 SCN1A SCN2A SCN3A SCN4A SCN8A SCN9A SCN10A DOCK7 DYNC1H1 GABRA2 | 1.30e-06 | 891 | 148 | 21 | GO:0030424 |
| GeneOntologyCellularComponent | dynein complex | 2.22e-06 | 54 | 148 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.72e-05 | 25 | 148 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 4.02e-05 | 10 | 148 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 1.20e-04 | 14 | 148 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 3.10e-04 | 19 | 148 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | node of Ranvier | 3.63e-04 | 20 | 148 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | GABA receptor complex | 4.21e-04 | 21 | 148 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | dendrite membrane | 6.66e-04 | 56 | 148 | 4 | GO:0032590 | |
| GeneOntologyCellularComponent | chloride channel complex | 7.12e-04 | 57 | 148 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | presynaptic membrane | 8.19e-04 | 277 | 148 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A GABRG1 GABRG3 GPER1 GRM3 NLGN4X SCN1A SCN2A SCN8A SCN10A IGSF9B GABRA2 | 9.25e-04 | 583 | 148 | 12 | GO:0097060 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.02e-03 | 161 | 148 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1A GABRG1 GABRG3 GPER1 SMURF1 CHAT RET GRM3 AR NLGN4X RAPGEF3 SCN1A SCN3A SCN8A BRINP2 IGSF9B DYNC1H1 GABRA2 EPHA8 | 1.10e-03 | 1228 | 148 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | axon initial segment | 1.11e-03 | 29 | 148 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.35e-03 | 31 | 148 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | T-tubule | 2.40e-03 | 79 | 148 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.42e-03 | 405 | 148 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | neuron projection membrane | 2.75e-03 | 82 | 148 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.33e-03 | 141 | 148 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | axoneme | 3.61e-03 | 207 | 148 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | symmetric synapse | 3.69e-03 | 13 | 148 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | ciliary plasm | 3.70e-03 | 208 | 148 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | motile cilium | 3.85e-03 | 355 | 148 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | leading edge membrane | 3.87e-03 | 210 | 148 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A RET TRBV20-1 KCNJ5 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ATP12A | 3.89e-03 | 785 | 148 | 13 | GO:0098797 |
| HumanPheno | Complex febrile seizure | 1.10e-08 | 16 | 57 | 6 | HP:0011172 | |
| HumanPheno | Focal automatism seizure | 6.53e-06 | 12 | 57 | 4 | HP:0032898 | |
| HumanPheno | Facial tics | 1.76e-05 | 15 | 57 | 4 | HP:0011468 | |
| HumanPheno | Generalized tonic seizure | 6.82e-05 | 64 | 57 | 6 | HP:0010818 | |
| HumanPheno | Photosensitive myoclonic seizure | 7.15e-05 | 8 | 57 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 7.15e-05 | 8 | 57 | 3 | HP:0200048 | |
| HumanPheno | Focal hemiclonic seizure | 1.50e-04 | 25 | 57 | 4 | HP:0006813 | |
| HumanPheno | EEG with generalized epileptiform discharges | CACNA1A UPB1 CHAT SCN1A SCN2A SCN3A SCN8A SCN9A DOCK7 PIGW GABRA2 | 1.57e-04 | 270 | 57 | 11 | HP:0011198 |
| HumanPheno | Hypsarrhythmia | 1.80e-04 | 185 | 57 | 9 | HP:0002521 | |
| HumanPheno | Simple febrile seizure | 2.04e-04 | 27 | 57 | 4 | HP:0011171 | |
| HumanPheno | Limited neck range of motion | 2.06e-04 | 11 | 57 | 3 | HP:0000466 | |
| HumanPheno | Facial paralysis | 2.06e-04 | 11 | 57 | 3 | HP:0007209 | |
| HumanPheno | Impulsivity | 2.18e-04 | 149 | 57 | 8 | HP:0100710 | |
| MousePheno | impaired muscle relaxation | 3.31e-06 | 28 | 118 | 5 | MP:0003157 | |
| MousePheno | abnormal posture | CACNA1A NPR2 RB1 SPNS2 SMURF1 CLCN7 SCN1A SCN8A SCN10A DYNC1H1 GABRA2 | 6.50e-06 | 243 | 118 | 11 | MP:0001504 |
| MousePheno | muscular atrophy | 1.64e-05 | 96 | 118 | 7 | MP:0002269 | |
| MousePheno | abnormal somatic hypermutation frequency | 1.70e-05 | 19 | 118 | 4 | MP:0004815 | |
| MousePheno | increased B cell apoptosis | 8.45e-05 | 28 | 118 | 4 | MP:0008782 | |
| MousePheno | skeletal muscle atrophy | 8.95e-05 | 54 | 118 | 5 | MP:0009417 | |
| MousePheno | increased germinal center B cell number | 1.27e-04 | 31 | 118 | 4 | MP:0008177 | |
| MousePheno | abnormal action potential | 1.32e-04 | 133 | 118 | 7 | MP:0005402 | |
| MousePheno | abnormal muscle relaxation | 1.61e-04 | 61 | 118 | 5 | MP:0004036 | |
| Domain | Na_channel_asu | 4.56e-16 | 10 | 144 | 8 | IPR001696 | |
| Domain | Na_trans_assoc | 4.56e-16 | 10 | 144 | 8 | IPR010526 | |
| Domain | Na_trans_assoc | 4.56e-16 | 10 | 144 | 8 | PF06512 | |
| Domain | Na_trans_cytopl | 1.52e-10 | 6 | 144 | 5 | PF11933 | |
| Domain | Na_trans_cytopl | 1.52e-10 | 6 | 144 | 5 | IPR024583 | |
| Domain | Channel_four-helix_dom | 4.92e-10 | 57 | 144 | 9 | IPR027359 | |
| Domain | - | 4.92e-10 | 57 | 144 | 9 | 1.20.120.350 | |
| Domain | FAM72 | 3.39e-09 | 4 | 144 | 4 | IPR026768 | |
| Domain | FAM72 | 3.39e-09 | 4 | 144 | 4 | PF14976 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.81e-08 | 14 | 144 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.81e-08 | 14 | 144 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.81e-08 | 14 | 144 | 5 | IPR013602 | |
| Domain | DHC_N2 | 4.81e-08 | 14 | 144 | 5 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.81e-08 | 14 | 144 | 5 | IPR011704 | |
| Domain | MT | 4.81e-08 | 14 | 144 | 5 | PF12777 | |
| Domain | AAA_8 | 4.81e-08 | 14 | 144 | 5 | PF12780 | |
| Domain | AAA_5 | 4.81e-08 | 14 | 144 | 5 | PF07728 | |
| Domain | DHC_fam | 7.17e-08 | 15 | 144 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 7.17e-08 | 15 | 144 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.17e-08 | 15 | 144 | 5 | IPR004273 | |
| Domain | DHC_N1 | 2.32e-07 | 8 | 144 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.32e-07 | 8 | 144 | 4 | IPR013594 | |
| Domain | Ion_trans_dom | 2.44e-07 | 114 | 144 | 9 | IPR005821 | |
| Domain | Ion_trans | 2.44e-07 | 114 | 144 | 9 | PF00520 | |
| Domain | IQ_motif_EF-hand-BS | 4.67e-07 | 90 | 144 | 8 | IPR000048 | |
| Domain | IQ | 3.02e-06 | 81 | 144 | 7 | SM00015 | |
| Domain | IQ | 7.62e-06 | 93 | 144 | 7 | PS50096 | |
| Domain | AAA | 1.60e-05 | 144 | 144 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 1.60e-05 | 144 | 144 | 8 | IPR003593 | |
| Domain | IQ | 1.79e-05 | 71 | 144 | 6 | PF00612 | |
| Domain | Hydrolase_3 | 5.18e-05 | 10 | 144 | 3 | PF08282 | |
| Domain | DM15 | 5.90e-05 | 2 | 144 | 2 | SM00684 | |
| Domain | DM15 | 5.90e-05 | 2 | 144 | 2 | IPR006607 | |
| Domain | - | 1.03e-04 | 32 | 144 | 4 | 3.40.1110.10 | |
| Domain | - | 1.03e-04 | 32 | 144 | 4 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.47e-04 | 35 | 144 | 4 | IPR023299 | |
| Domain | P_typ_ATPase_c | 1.54e-04 | 14 | 144 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.54e-04 | 14 | 144 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.54e-04 | 14 | 144 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.54e-04 | 14 | 144 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.54e-04 | 14 | 144 | 3 | PF16209 | |
| Domain | ATPase_P-typ_P_site | 1.65e-04 | 36 | 144 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.65e-04 | 36 | 144 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.65e-04 | 36 | 144 | 4 | PS00154 | |
| Domain | GABBAg_rcpt | 1.76e-04 | 3 | 144 | 2 | IPR005437 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.84e-04 | 37 | 144 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.84e-04 | 37 | 144 | 4 | PF00122 | |
| Domain | FOXP-CC | 3.51e-04 | 4 | 144 | 2 | PF16159 | |
| Domain | FOXP-CC | 3.51e-04 | 4 | 144 | 2 | IPR032354 | |
| Domain | GABAA/Glycine_rcpt | 7.10e-04 | 23 | 144 | 3 | IPR006028 | |
| Domain | LA | 1.21e-03 | 7 | 144 | 2 | SM00715 | |
| Domain | HTH_LA | 1.21e-03 | 7 | 144 | 2 | PS50961 | |
| Domain | La | 1.21e-03 | 7 | 144 | 2 | PF05383 | |
| Domain | Lupus_La_RNA-bd | 1.21e-03 | 7 | 144 | 2 | IPR006630 | |
| Domain | Thioredoxin | 1.72e-03 | 31 | 144 | 3 | PF00085 | |
| Domain | WHTH_DNA-bd_dom | 2.75e-03 | 242 | 144 | 7 | IPR011991 | |
| Domain | DHR-1_domain | 3.10e-03 | 11 | 144 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.10e-03 | 11 | 144 | 2 | PS51651 | |
| Domain | DHR_1 | 3.10e-03 | 11 | 144 | 2 | PS51650 | |
| Domain | DHR-2 | 3.10e-03 | 11 | 144 | 2 | PF06920 | |
| Domain | DOCK | 3.10e-03 | 11 | 144 | 2 | IPR026791 | |
| Domain | MACPF | 3.10e-03 | 11 | 144 | 2 | PF01823 | |
| Domain | DOCK_C | 3.10e-03 | 11 | 144 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.10e-03 | 11 | 144 | 2 | PF14429 | |
| Domain | DHR-2 | 3.10e-03 | 11 | 144 | 2 | IPR027357 | |
| Domain | HAD-like_dom | 3.25e-03 | 79 | 144 | 4 | IPR023214 | |
| Domain | MACPF | 3.70e-03 | 12 | 144 | 2 | IPR020864 | |
| Domain | MACPF | 3.70e-03 | 12 | 144 | 2 | SM00457 | |
| Domain | Thioredoxin_domain | 3.86e-03 | 41 | 144 | 3 | IPR013766 | |
| Domain | THIOREDOXIN_2 | 4.42e-03 | 43 | 144 | 3 | PS51352 | |
| Domain | Neurotransmitter_ion_chnl_CS | 5.03e-03 | 45 | 144 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 5.35e-03 | 46 | 144 | 3 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 5.68e-03 | 47 | 144 | 3 | IPR006029 | |
| Domain | - | 5.68e-03 | 47 | 144 | 3 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 5.68e-03 | 47 | 144 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 5.68e-03 | 47 | 144 | 3 | PS00236 | |
| Domain | Neur_channel | 5.68e-03 | 47 | 144 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 5.68e-03 | 47 | 144 | 3 | IPR006202 | |
| Domain | EF-hand-dom_pair | 6.93e-03 | 287 | 144 | 7 | IPR011992 | |
| Domain | - | 6.94e-03 | 218 | 144 | 6 | 1.10.10.10 | |
| Domain | Thioredoxin_CS | 7.44e-03 | 17 | 144 | 2 | IPR017937 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 9.64e-11 | 31 | 114 | 8 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.28e-10 | 32 | 114 | 8 | M27455 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.05e-06 | 130 | 114 | 9 | M27454 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | NPR2 SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A MYBPC3 | 5.69e-06 | 203 | 114 | 10 | M5485 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 6.02e-06 | 121 | 114 | 8 | M872 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | ATG5 GABRG1 GRM3 NLGN4X SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A GABRA2 | 8.23e-06 | 367 | 114 | 13 | M48346 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.17e-05 | 27 | 114 | 4 | M47755 | |
| Pathway | WP_DRAVET_SYNDROME | 7.15e-05 | 28 | 114 | 4 | M45519 | |
| Pubmed | 8.21e-16 | 9 | 149 | 7 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 5.59e-15 | 6 | 149 | 6 | 23652591 | |
| Pubmed | 9.35e-12 | 13 | 149 | 6 | 15123669 | ||
| Pubmed | 1.68e-10 | 9 | 149 | 5 | 15746173 | ||
| Pubmed | 3.24e-10 | 4 | 149 | 4 | 17537961 | ||
| Pubmed | 3.24e-10 | 4 | 149 | 4 | 35031483 | ||
| Pubmed | 3.24e-10 | 4 | 149 | 4 | 29578003 | ||
| Pubmed | Fam72a enforces error-prone DNA repair during antibody diversification. | 3.24e-10 | 4 | 149 | 4 | 34819671 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RB1 PTDSS1 GPAT3 HAT1 SMPD4 CAT URB2 INTS8 GGCX STRIP1 DHX15 TMX1 ATP6V1H GTF2H4 OXA1L BCAP29 NOM1 MCU CLPTM1 DOCK7 FAR1 TMX3 SLC29A1 AQR | 3.61e-10 | 1203 | 149 | 24 | 29180619 |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA1A CLCN7 KCNJ5 SCN1A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A | 5.10e-10 | 139 | 149 | 10 | 16985003 |
| Pubmed | 1.61e-09 | 5 | 149 | 4 | 8812438 | ||
| Pubmed | Identification and characterisation of the novel amyloid-beta peptide-induced protein p17. | 1.61e-09 | 5 | 149 | 4 | 19755123 | |
| Pubmed | 1.61e-09 | 5 | 149 | 4 | 26206078 | ||
| Pubmed | 1.61e-09 | 5 | 149 | 4 | 17724025 | ||
| Pubmed | FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation. | 4.82e-09 | 6 | 149 | 4 | 34819670 | |
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 19284629 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 33895391 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 23859570 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 12610651 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 19699781 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 18784617 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 17544618 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 32845893 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 28518218 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 17928448 | ||
| Pubmed | 7.71e-08 | 3 | 149 | 3 | 14973256 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.56e-07 | 12 | 149 | 4 | 30175250 | |
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 10198179 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 22260870 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 35801810 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 11175280 | ||
| Pubmed | 3.07e-07 | 4 | 149 | 3 | 21156207 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 3.07e-07 | 4 | 149 | 3 | 8974318 | |
| Pubmed | 3.13e-07 | 14 | 149 | 4 | 9373155 | ||
| Pubmed | 4.26e-07 | 15 | 149 | 4 | 1741163 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 4.26e-07 | 15 | 149 | 4 | 9726281 | |
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 1679748 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 7.66e-07 | 5 | 149 | 3 | 22875929 | |
| Pubmed | 7.66e-07 | 5 | 149 | 3 | 24337656 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 16029194 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 23711479 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 10447508 | ||
| Pubmed | 1.53e-06 | 6 | 149 | 3 | 25947375 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 2.66e-06 | 7 | 149 | 3 | 25818041 | |
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 16080114 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 2.66e-06 | 7 | 149 | 3 | 24440715 | |
| Pubmed | 2.66e-06 | 7 | 149 | 3 | 23575686 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 UXS1 MAN2A2 ERP44 PTDSS1 LRP1B GGCX DHX15 TMX1 BCAP29 ZDHHC6 PGAP1 CLPTM1 TMEM131L TMX3 SLC29A1 GNS PLXNA1 | 4.23e-06 | 1201 | 149 | 18 | 35696571 |
| Pubmed | 4.25e-06 | 8 | 149 | 3 | 25101983 | ||
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 6.35e-06 | 9 | 149 | 3 | 8854872 | |
| Pubmed | ERP44 COQ8B PTDSS1 HAT1 RFC5 GGCX TMX1 OXA1L MCU CLPTM1 TMX3 DYNC1H1 EPHA8 | 8.79e-06 | 686 | 149 | 13 | 28380382 | |
| Pubmed | Common variants associated with general and MMR vaccine-related febrile seizures. | 9.05e-06 | 10 | 149 | 3 | 25344690 | |
| Pubmed | Forkhead Box Protein P1 Is Dispensable for Retina but Essential for Lens Development. | 9.05e-06 | 10 | 149 | 3 | 28384713 | |
| Pubmed | 9.05e-06 | 10 | 149 | 3 | 20583128 | ||
| Pubmed | 9.30e-06 | 31 | 149 | 4 | 19736351 | ||
| Pubmed | FKBP15 GPAT3 CHM GGCX TMX1 CLCN7 TBC1D22A TMEM131L PLEKHM3 SLC29A1 PLXNA1 | 1.22e-05 | 504 | 149 | 11 | 34432599 | |
| Pubmed | 1.24e-05 | 11 | 149 | 3 | 39137998 | ||
| Pubmed | 1.65e-05 | 12 | 149 | 3 | 21914794 | ||
| Pubmed | 1.65e-05 | 12 | 149 | 3 | 8169823 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 1.82e-05 | 2 | 149 | 2 | 37901435 | |
| Pubmed | RET signaling is required for survival and normal function of nonpeptidergic nociceptors. | 1.82e-05 | 2 | 149 | 2 | 20237269 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 18079277 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 19234228 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 1.82e-05 | 2 | 149 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 1.82e-05 | 2 | 149 | 2 | 10827969 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 21099110 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 19694741 | ||
| Pubmed | Mouse germ cell-less as an essential component for nuclear integrity. | 1.82e-05 | 2 | 149 | 2 | 12556490 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 1.82e-05 | 2 | 149 | 2 | 11245985 | |
| Pubmed | RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner. | 1.82e-05 | 2 | 149 | 2 | 34065204 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 17976953 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 1.82e-05 | 2 | 149 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 1.82e-05 | 2 | 149 | 2 | 23016767 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 27153334 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 1.82e-05 | 2 | 149 | 2 | 24990319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 1.82e-05 | 2 | 149 | 2 | 25172946 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 31439038 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 31943325 | ||
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 1.82e-05 | 2 | 149 | 2 | 15249644 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 27690330 | ||
| Pubmed | RBEL1 is required for osteosarcoma cell proliferation via inhibiting retinoblastoma 1. | 1.82e-05 | 2 | 149 | 2 | 26676380 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 10448096 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.82e-05 | 2 | 149 | 2 | 27174182 | |
| Pubmed | Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein. | 1.82e-05 | 2 | 149 | 2 | 27760327 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 18601978 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 1.82e-05 | 2 | 149 | 2 | 23965409 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 26087834 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 1.82e-05 | 2 | 149 | 2 | 19465131 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 31790348 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 1.82e-05 | 2 | 149 | 2 | 23735284 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 29649454 | ||
| Pubmed | Mutagenic insertion and chromosome engineering resource (MICER). | 1.82e-05 | 2 | 149 | 2 | 15235602 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 35759955 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 9675141 | ||
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 1.82e-05 | 2 | 149 | 2 | 16111501 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 27148695 | ||
| Interaction | SCN11A interactions | 4.76e-08 | 15 | 143 | 5 | int:SCN11A | |
| Interaction | GPR182 interactions | EXOC6 UXS1 COQ8B GPAT3 SMPD4 URB2 INTS8 GGCX FANCD2 ATP6V1H GTF2H4 OXA1L NOM1 MCU TNFAIP2 ATP12A | 1.55e-07 | 455 | 143 | 16 | int:GPR182 |
| Interaction | MGARP interactions | COQ8B URB2 INTS8 FANCD2 ATP6V1H GTF2H4 OXA1L NOM1 MCU TNFAIP2 ATP12A | 5.47e-07 | 222 | 143 | 11 | int:MGARP |
| Interaction | APLNR interactions | EXOC6 COQ8B URB2 GGCX FANCD2 OXA1L MCU TNFAIP2 ATP12A SLC29A1 | 2.72e-06 | 211 | 143 | 10 | int:APLNR |
| Interaction | RNF4 interactions | RB1 PTDSS1 GPAT3 HAT1 SMPD4 CAT URB2 INTS8 AR GGCX STRIP1 DHX15 TMX1 GMCL1 ATP6V1H GTF2H4 OXA1L BCAP29 NOM1 MCU CLPTM1 DOCK7 FAR1 TMX3 SLC29A1 AQR | 6.30e-06 | 1412 | 143 | 26 | int:RNF4 |
| Interaction | HLA-B interactions | DPP4 UXS1 GPAT3 SMPD4 INTS8 GGCX FANCD2 ATP6V1H B3GNT2 ATP12A | 8.21e-06 | 239 | 143 | 10 | int:HLA-B |
| Interaction | MATK interactions | 1.30e-05 | 43 | 143 | 5 | int:MATK | |
| Interaction | SCN4B interactions | 1.91e-05 | 8 | 143 | 3 | int:SCN4B | |
| Interaction | SCN5A interactions | 2.02e-05 | 47 | 143 | 5 | int:SCN5A | |
| Interaction | CACNA1D interactions | 2.31e-05 | 24 | 143 | 4 | int:CACNA1D | |
| Interaction | TENT5A interactions | 2.96e-05 | 84 | 143 | 6 | int:TENT5A | |
| Interaction | SCN1A interactions | 5.03e-05 | 29 | 143 | 4 | int:SCN1A | |
| Interaction | SCN10A interactions | 5.54e-05 | 11 | 143 | 3 | int:SCN10A | |
| Interaction | SEC62 interactions | MAN2A2 PTDSS1 GPAT3 SMPD4 GGCX TMX1 CLCN7 MCU SCN4A CLPTM1 TMEM131L ATP12A TMX3 | 6.64e-05 | 506 | 143 | 13 | int:SEC62 |
| Interaction | FES interactions | 7.25e-05 | 61 | 143 | 5 | int:FES | |
| Interaction | CANX interactions | ABCC3 DPP4 DNAH3 UXS1 ERP44 DNAH10 GPAT3 SMPD4 RET TRRAP GGCX FANCD2 TMX1 ZDHHC6 B3GNT2 PGAP1 CLPTM1 BRINP2 PLEKHM3 TMX3 DNAH9 EPHA8 | 8.01e-05 | 1261 | 143 | 22 | int:CANX |
| Interaction | BNC2 interactions | 9.50e-05 | 13 | 143 | 3 | int:BNC2 | |
| Interaction | SSR1 interactions | DPP4 COQ8B PTDSS1 GPAT3 SMPD4 FANCD2 TMX1 CLCN7 BCAP29 B3GNT2 CLPTM1 TMEM131L | 9.59e-05 | 453 | 143 | 12 | int:SSR1 |
| Interaction | NALCN interactions | 1.20e-04 | 14 | 143 | 3 | int:NALCN | |
| Interaction | POMK interactions | 1.40e-04 | 271 | 143 | 9 | int:POMK | |
| Interaction | XAGE2 interactions | 1.50e-04 | 15 | 143 | 3 | int:XAGE2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 2.12e-07 | 127 | 149 | 7 | chr2q24 | |
| Cytoband | 2q24.3 | 1.82e-05 | 16 | 149 | 3 | 2q24.3 | |
| Cytoband | 4p12 | 3.67e-05 | 20 | 149 | 3 | 4p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p12 | 8.25e-05 | 26 | 149 | 3 | chr4p12 | |
| Cytoband | 2q24 | 5.65e-04 | 11 | 149 | 2 | 2q24 | |
| Cytoband | 4q21.23 | 7.97e-04 | 13 | 149 | 2 | 4q21.23 | |
| Cytoband | 10q11.2 | 9.28e-04 | 14 | 149 | 2 | 10q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q12 | 1.55e-03 | 18 | 149 | 2 | chr15q12 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 6.94e-15 | 9 | 106 | 7 | 1203 | |
| GeneFamily | Dyneins, axonemal | 2.50e-06 | 17 | 106 | 4 | 536 | |
| GeneFamily | ATPase phospholipid transporting | 8.47e-05 | 15 | 106 | 3 | 1210 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.77e-04 | 19 | 106 | 3 | 563 | |
| GeneFamily | Protein disulfide isomerases | 2.41e-04 | 21 | 106 | 3 | 692 | |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 7.01e-04 | 7 | 106 | 2 | 625 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1A GABRG1 FKBP15 PDE4C SMURF1 LARP1B GRM3 LRP1B STRIP1 NLGN4X SCN1A SCN2A PGAP1 SCN3A SCN8A SCN9A PAPPA IGSF9B PLXNA1 GABRA2 | 4.36e-06 | 1106 | 148 | 20 | M39071 |
| Coexpression | GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN | 1.46e-05 | 193 | 148 | 8 | M9712 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.89e-09 | 162 | 148 | 9 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-08 | 145 | 148 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 7.50e-07 | 151 | 148 | 7 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.95e-07 | 155 | 148 | 7 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-06 | 169 | 148 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-06 | 169 | 148 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.86e-06 | 173 | 148 | 7 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 178 | 148 | 7 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 178 | 148 | 7 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.71e-06 | 183 | 148 | 7 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-06 | 183 | 148 | 7 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.91e-06 | 185 | 148 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.91e-06 | 185 | 148 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-06 | 191 | 148 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-06 | 191 | 148 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-06 | 191 | 148 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.72e-06 | 192 | 148 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-06 | 194 | 148 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 3.98e-06 | 194 | 148 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.12e-06 | 195 | 148 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 4.26e-06 | 196 | 148 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-06 | 197 | 148 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-06 | 197 | 148 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-06 | 197 | 148 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-06 | 197 | 148 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.40e-06 | 197 | 148 | 7 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-06 | 128 | 148 | 6 | 003e133469899a9abe3a7f6d7f580583b281f412 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.55e-06 | 198 | 148 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.86e-06 | 200 | 148 | 7 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.86e-06 | 200 | 148 | 7 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.84e-05 | 164 | 148 | 6 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 168 | 148 | 6 | fa7c0303918cea04e3f4c4f3cb079be19004d214 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 168 | 148 | 6 | 7edcab103c69e928d5c19a0d218ffb3ae32f9e70 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-05 | 169 | 148 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 171 | 148 | 6 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 171 | 148 | 6 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.49e-05 | 173 | 148 | 6 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.65e-05 | 175 | 148 | 6 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 175 | 148 | 6 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 175 | 148 | 6 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 175 | 148 | 6 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.65e-05 | 175 | 148 | 6 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.65e-05 | 175 | 148 | 6 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-05 | 179 | 148 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.11e-05 | 180 | 148 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.11e-05 | 180 | 148 | 6 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.30e-05 | 182 | 148 | 6 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.30e-05 | 182 | 148 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 3.41e-05 | 183 | 148 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.51e-05 | 184 | 148 | 6 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.62e-05 | 185 | 148 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.73e-05 | 186 | 148 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.73e-05 | 186 | 148 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 3.96e-05 | 188 | 148 | 6 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.96e-05 | 188 | 148 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.96e-05 | 188 | 148 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.96e-05 | 188 | 148 | 6 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.96e-05 | 188 | 148 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 188 | 148 | 6 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 148 | 6 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.08e-05 | 189 | 148 | 6 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 189 | 148 | 6 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.08e-05 | 189 | 148 | 6 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.08e-05 | 189 | 148 | 6 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 148 | 6 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 4.08e-05 | 189 | 148 | 6 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.08e-05 | 189 | 148 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.08e-05 | 189 | 148 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.08e-05 | 189 | 148 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.20e-05 | 190 | 148 | 6 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.20e-05 | 190 | 148 | 6 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 4.20e-05 | 190 | 148 | 6 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.20e-05 | 190 | 148 | 6 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.20e-05 | 190 | 148 | 6 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 4.32e-05 | 191 | 148 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 4.32e-05 | 191 | 148 | 6 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 4.32e-05 | 191 | 148 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.45e-05 | 192 | 148 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.45e-05 | 192 | 148 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 4.45e-05 | 192 | 148 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.58e-05 | 193 | 148 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.58e-05 | 193 | 148 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.58e-05 | 193 | 148 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.58e-05 | 193 | 148 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.58e-05 | 193 | 148 | 6 | 4fb020f11fd7aff06952bfeaabc79b2c7b8873f6 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.72e-05 | 194 | 148 | 6 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 194 | 148 | 6 | ad1aacff97beb76f4211942676e1d5e84087d44e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 194 | 148 | 6 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 194 | 148 | 6 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 194 | 148 | 6 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 194 | 148 | 6 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.72e-05 | 194 | 148 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.72e-05 | 194 | 148 | 6 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.72e-05 | 194 | 148 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-05 | 194 | 148 | 6 | fdd59b1e036b2d6d8877e1a920a0e56a91a2a882 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.75e-05 | 60 | 148 | 4 | aa75fef294803ec6396c7d2c1f51d52bc4a5b43f | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.75e-05 | 60 | 148 | 4 | 069fbabfd0e48e5809ff01a026439fd0bd017779 | |
| Drug | APETx1, Anthopleura elegantissima | 6.04e-11 | 6 | 146 | 5 | ctd:C475726 | |
| Drug | tetradotoxin | CACNA1A GABRG1 GABRG3 NPR2 CHAT GRM3 ITIH4 OXA1L SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A POLL TACR2 GABRA2 | 3.17e-10 | 428 | 146 | 18 | CID000020382 |
| Drug | potassium | CACNA1A GABRG1 GABRG3 NPR2 RB1 SPEF2 CAT CHM GRM3 GGCX KRIT1 CLCN7 RAPGEF3 KCNJ5 SCN2A SCN3A SCN4A CLPTM1 SCN7A SCN9A SCN10A POLL TNFAIP2 ATP12A GABRA2 | 5.94e-09 | 1008 | 146 | 25 | CID000000813 |
| Drug | cyfluthrin | 2.64e-08 | 29 | 146 | 6 | ctd:C052570 | |
| Drug | NSC93767 | 4.95e-08 | 32 | 146 | 6 | CID000005658 | |
| Drug | Zonisamide | 5.89e-08 | 17 | 146 | 5 | DB00909 | |
| Drug | Scorpion Venoms | 8.11e-08 | 18 | 146 | 5 | ctd:D012604 | |
| Drug | lidocaine | GABRG1 GABRG3 RET SCN3A SCN4A SCN7A SCN9A SCN10A TNFAIP2 GABRA2 | 8.64e-08 | 160 | 146 | 10 | CID000003676 |
| Drug | diprafenone | 1.09e-07 | 19 | 146 | 5 | CID000071249 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.11e-07 | 8 | 146 | 4 | ctd:C489827 | |
| Drug | benzocaine | 1.24e-07 | 37 | 146 | 6 | CID000002337 | |
| Drug | gabapentin | CACNA1A GABRG1 GABRG3 GRM3 SCN3A SCN4A SCN7A SCN9A SCN10A GABRA2 | 1.44e-07 | 169 | 146 | 10 | CID000003446 |
| Drug | sodium | GABRG1 GABRG3 ABCC3 DPP4 SLC6A16 CHAT CAT KRIT1 ATP6V1H ASMTL KCNJ5 SCN2A SCN3A SCN4A SLC6A20 SCN7A SCN9A SCN10A POLL ATP12A SLC29A1 GABRA2 | 1.60e-07 | 944 | 146 | 22 | CID000000923 |
| Drug | riluzole | CACNA1A GABRG1 GABRG3 GRM3 SCN3A SCN4A SCN7A SCN9A SCN10A GABRA2 | 1.90e-07 | 174 | 146 | 10 | CID000005070 |
| Drug | saxitoxin | 1.97e-07 | 65 | 146 | 7 | CID000037165 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 2.58e-07 | 3 | 146 | 3 | ctd:C561228 | |
| Drug | strychnine HCl | GABRG1 GABRG3 GRM3 SCN3A SCN4A SCN7A SCN9A SCN10A POLL GABRA2 | 2.74e-07 | 181 | 146 | 10 | CID000005304 |
| Drug | AC1NT1AF | 4.85e-07 | 25 | 146 | 5 | CID005322157 | |
| Drug | Pirmenolum | 5.97e-07 | 26 | 146 | 5 | CID000004853 | |
| Drug | procaine | 6.51e-07 | 153 | 146 | 9 | CID000004914 | |
| Drug | PbTx-1 | 7.29e-07 | 27 | 146 | 5 | CID006437089 | |
| Drug | AC1L1MOZ | 7.29e-07 | 27 | 146 | 5 | CID000031958 | |
| Drug | nefopam | 7.29e-07 | 27 | 146 | 5 | CID000004450 | |
| Drug | lamotrigine | 8.35e-07 | 116 | 146 | 8 | CID000003878 | |
| Drug | paraben | 8.83e-07 | 28 | 146 | 5 | CID000007175 | |
| Drug | QX-314 | 9.82e-07 | 82 | 146 | 7 | CID000003925 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.03e-06 | 4 | 146 | 3 | ctd:C501880 | |
| Drug | ketamine | GABRG1 GABRG3 GRM3 GGCX SCN3A SCN4A SCN7A SCN9A SCN10A TNFAIP2 GABRA2 | 1.06e-06 | 262 | 146 | 11 | CID000003821 |
| Drug | tocainide | 1.27e-06 | 30 | 146 | 5 | CID000038945 | |
| Drug | pentobarbital | GABRG1 GABRG3 CAT GRM3 SCN3A SCN4A SCN7A SCN9A SCN10A GABRA2 | 1.92e-06 | 224 | 146 | 10 | CID000004737 |
| Drug | 5-hydroxypropafenone | 2.42e-06 | 34 | 146 | 5 | CID000107927 | |
| Drug | biotinyl-L-lysine | 3.51e-06 | 99 | 146 | 7 | CID000083814 | |
| Drug | isradipine | 3.75e-06 | 100 | 146 | 7 | CID000003784 | |
| Drug | AC1L1CQC | 3.79e-06 | 65 | 146 | 6 | CID000002012 | |
| Drug | propofol | 4.10e-06 | 191 | 146 | 9 | CID000004943 | |
| Drug | mexiletine | 4.15e-06 | 66 | 146 | 6 | CID000004178 | |
| Drug | disopyramide | 4.15e-06 | 66 | 146 | 6 | CID000003114 | |
| Drug | resiniferatoxin | 4.15e-06 | 66 | 146 | 6 | CID000104826 | |
| Drug | aprindine | 4.28e-06 | 38 | 146 | 5 | CID000002218 | |
| Drug | AC1Q5UBL | 4.71e-06 | 146 | 146 | 8 | CID000005466 | |
| Drug | decamethrin | 4.71e-06 | 146 | 146 | 8 | ctd:C017180 | |
| Drug | salbutamol | 4.71e-06 | 146 | 146 | 8 | CID000002083 | |
| Drug | beta-alanine | 4.88e-06 | 104 | 146 | 7 | CID000000239 | |
| Drug | fenpropathrin | 5.09e-06 | 6 | 146 | 3 | ctd:C044267 | |
| Drug | S-ropivacaine | 5.56e-06 | 40 | 146 | 5 | CID000071273 | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 5.72e-06 | 199 | 146 | 9 | 3618_UP | |
| Drug | ZK 93426 | 5.84e-06 | 19 | 146 | 4 | CID000115210 | |
| Drug | Biliton | 6.30e-06 | 41 | 146 | 5 | CID000002974 | |
| Drug | T2755 | 6.37e-06 | 71 | 146 | 6 | CID000005514 | |
| Drug | diphenhydramine | 8.77e-06 | 75 | 146 | 6 | CID000003100 | |
| Drug | chloride | GABRG1 GABRG3 LPAR3 NPR2 SLC6A16 HAT1 CAT CHM GMCL1 GMCL2 OXA1L CLCN7 SCN2A SCN4A SLC6A20 POLL SLC29A1 GNS DYNC1H1 GABRA2 | 9.62e-06 | 1029 | 146 | 20 | CID000000312 |
| Drug | pilsicainide | 1.12e-05 | 46 | 146 | 5 | CID000004820 | |
| Drug | spiradoline | 1.12e-05 | 46 | 146 | 5 | CID000005620 | |
| Drug | isoflurane | GABRG1 GABRG3 GRM3 SCN3A SCN4A SCN7A SCN9A SCN10A TNFAIP2 GABRA2 | 1.33e-05 | 279 | 146 | 10 | CID000003763 |
| Drug | morphine hydrochloride | CACNA1A GABRG1 GABRG3 ABCC3 CAT GRM3 ITIH4 SCN9A POLL TACR2 TNFAIP2 HAS3 GABRA2 | 1.41e-05 | 481 | 146 | 13 | CID000004253 |
| Drug | dopamine | CACNA1A GABRG1 GABRG3 NPR2 SLC6A16 PAQR5 CHAT CAT RET GRM3 AR OXA1L KCNJ5 TNFAIP2 SLC29A1 GABRA2 | 1.48e-05 | 715 | 146 | 16 | CID000000681 |
| Drug | indoxacarb | 1.54e-05 | 49 | 146 | 5 | CID000107720 | |
| Drug | DNQX | 1.58e-05 | 83 | 146 | 6 | CID003899541 | |
| Drug | bepridil | 1.72e-05 | 126 | 146 | 7 | CID000002351 | |
| Drug | sodium oxalate | 2.11e-05 | 9 | 146 | 3 | CID000006125 | |
| Drug | NSC7524 | 2.36e-05 | 182 | 146 | 8 | CID000005657 | |
| Drug | AC1NSN3X | 2.49e-05 | 54 | 146 | 5 | CID005366189 | |
| Drug | forskolin from Coleus forskohlii | GABRG1 GABRG3 LPAR3 NPR2 PDE4A PDE4C RET GRM3 INTS8 AR KRIT1 RAPGEF3 SCN3A SCN4A SCN7A SCN9A SCN10A TNFAIP2 GABRA2 | 2.68e-05 | 1013 | 146 | 19 | CID000003413 |
| Drug | isoproterenol | CACNA1A NPR2 PDE4A PDE4C CAT AR CLCN7 RAPGEF3 SCN3A SCN4A SCN7A SCN9A SCN10A TNFAIP2 MYBPC3 | 2.72e-05 | 669 | 146 | 15 | CID000003779 |
| Drug | Dichlorodiphenyldichloroethane | 3.40e-05 | 29 | 146 | 4 | ctd:D003632 | |
| Drug | triamterene | 3.53e-05 | 58 | 146 | 5 | CID000005546 | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 4.00e-05 | 196 | 146 | 8 | 3604_UP | |
| Drug | CHEMBL83995 | 4.08e-05 | 2 | 146 | 2 | CID009571169 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 4.08e-05 | 2 | 146 | 2 | ctd:C502265 | |
| Drug | fosazepam | 4.10e-05 | 11 | 146 | 3 | CID000037114 | |
| Drug | C19H18ClN3O | 4.10e-05 | 11 | 146 | 3 | CID000027452 | |
| Drug | flutoprazepam | 4.10e-05 | 11 | 146 | 3 | CID000003400 | |
| Drug | Arfendazam | 4.10e-05 | 11 | 146 | 3 | CID000065803 | |
| Drug | camazepam | 4.10e-05 | 11 | 146 | 3 | CID000037367 | |
| Drug | Bu-1014 | 4.10e-05 | 11 | 146 | 3 | CID015942721 | |
| Drug | Zapizolam | 4.10e-05 | 11 | 146 | 3 | CID000068832 | |
| Drug | Reclazepam | 4.10e-05 | 11 | 146 | 3 | CID003052777 | |
| Drug | iclazepam | 4.10e-05 | 11 | 146 | 3 | CID000068777 | |
| Drug | menitrazepam | 4.10e-05 | 11 | 146 | 3 | CID000189875 | |
| Drug | Serin hydrazid | 4.10e-05 | 11 | 146 | 3 | CID000041637 | |
| Drug | sulazepam | 4.10e-05 | 11 | 146 | 3 | CID000017931 | |
| Drug | elfazepam | 4.10e-05 | 11 | 146 | 3 | CID000065445 | |
| Drug | triflubazam | 4.10e-05 | 11 | 146 | 3 | CID000031157 | |
| Drug | uldazepam | 4.10e-05 | 11 | 146 | 3 | CID000034274 | |
| Drug | gidazepam | 4.10e-05 | 11 | 146 | 3 | CID000121919 | |
| Drug | fletazepam | 4.10e-05 | 11 | 146 | 3 | CID000036834 | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 4.30e-05 | 198 | 146 | 8 | 5409_UP | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A | 4.30e-05 | 198 | 146 | 8 | 4293_DN | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.30e-05 | 198 | 146 | 8 | 4102_UP | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.30e-05 | 198 | 146 | 8 | 5628_UP | |
| Drug | trimethoprim | 4.30e-05 | 99 | 146 | 6 | CID000005578 | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 4.45e-05 | 199 | 146 | 8 | 2320_UP | |
| Drug | 4-AP | 4.49e-05 | 258 | 146 | 9 | CID000001727 | |
| Drug | zonisamide | 4.88e-05 | 62 | 146 | 5 | CID000005734 | |
| Drug | 3-aminopropylphosphinic acid | 5.07e-05 | 32 | 146 | 4 | CID006335948 | |
| Drug | AP-7 | 5.28e-05 | 63 | 146 | 5 | CID000003122 | |
| Drug | methanethiosulfonate | 5.38e-05 | 103 | 146 | 6 | CID004188587 | |
| Drug | SB-205384 | 5.45e-05 | 12 | 146 | 3 | CID000197690 | |
| Drug | U-93631 | 5.45e-05 | 12 | 146 | 3 | CID000197626 | |
| Drug | haloxazolam | 5.45e-05 | 12 | 146 | 3 | CID000003563 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.32e-17 | 10 | 146 | 8 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.32e-17 | 10 | 146 | 8 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.44e-16 | 12 | 146 | 8 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | CACNA1A LRP1B SCN1A SCN2A SCN3A SCN4A SCN7A SCN8A SCN9A SCN10A ATP12A DYNC1H1 | 3.49e-11 | 163 | 146 | 12 | DOID:1826 (implicated_via_orthology) |
| Disease | progressive familial intrahepatic cholestasis (implicated_via_orthology) | 1.19e-07 | 3 | 146 | 3 | DOID:0070221 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.93e-06 | 22 | 146 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Seizure, Febrile, Simple | 4.09e-06 | 7 | 146 | 3 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 4.09e-06 | 7 | 146 | 3 | C0751057 | |
| Disease | Autistic Disorder | 6.50e-06 | 261 | 146 | 9 | C0004352 | |
| Disease | Alcoholic Intoxication, Chronic | 8.04e-06 | 268 | 146 | 9 | C0001973 | |
| Disease | Febrile Convulsions | 9.75e-06 | 9 | 146 | 3 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 9.75e-06 | 9 | 146 | 3 | C3502809 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 2.43e-05 | 2 | 146 | 2 | C4551549 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 3.27e-05 | 13 | 146 | 3 | C0751122 | |
| Disease | epilepsy | 5.05e-05 | 41 | 146 | 4 | EFO_0000474 | |
| Disease | MMR-related febrile seizures | 5.17e-05 | 15 | 146 | 3 | EFO_0006519 | |
| Disease | B Virus Infection | 7.27e-05 | 3 | 146 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 7.27e-05 | 3 | 146 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 7.27e-05 | 3 | 146 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 7.27e-05 | 3 | 146 | 2 | C0019372 | |
| Disease | Primary Erythermalgia | 7.27e-05 | 3 | 146 | 2 | C0014805 | |
| Disease | Familial or sporadic hemiplegic migraine | 7.27e-05 | 3 | 146 | 2 | cv:CN295307 | |
| Disease | Familial hemiplegic migraine | 7.27e-05 | 3 | 146 | 2 | cv:C0338484 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 7.27e-05 | 3 | 146 | 2 | C1833661 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 9.17e-05 | 18 | 146 | 3 | HP_0002373 | |
| Disease | Heart Block | 1.45e-04 | 4 | 146 | 2 | C0018794 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 1.45e-04 | 4 | 146 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | Auriculo-Ventricular Dissociation | 1.45e-04 | 4 | 146 | 2 | C0004331 | |
| Disease | Familial benign neonatal epilepsy | 3.60e-04 | 6 | 146 | 2 | C0220669 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 5.02e-04 | 7 | 146 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Congenital Pain Insensitivity | 5.02e-04 | 7 | 146 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 5.02e-04 | 7 | 146 | 2 | C0020075 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 5.02e-04 | 7 | 146 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | amino acid measurement | GABRG1 GABRG3 LPAR3 PTDSS1 SMURF1 LARP1 SCN4A BRINP2 OR1P1 GABRA2 FAM87A | 5.78e-04 | 678 | 146 | 11 | EFO_0005134 |
| Disease | Early Childhood Epilepsy, Myoclonic | 6.68e-04 | 8 | 146 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 6.68e-04 | 8 | 146 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 6.68e-04 | 8 | 146 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 6.68e-04 | 8 | 146 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 6.68e-04 | 8 | 146 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 6.68e-04 | 8 | 146 | 2 | C0393703 | |
| Disease | congestive heart failure (is_marker_for) | 7.46e-04 | 82 | 146 | 4 | DOID:6000 (is_marker_for) | |
| Disease | Myoclonic Epilepsy | 8.56e-04 | 9 | 146 | 2 | C0014550 | |
| Disease | Congenital myasthenic syndrome | 1.07e-03 | 10 | 146 | 2 | cv:C0751882 | |
| Disease | quality of life during menstruation measurement, aggressive behavior | 1.07e-03 | 10 | 146 | 2 | EFO_0003015, EFO_0009366 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.07e-03 | 10 | 146 | 2 | C0917800 | |
| Disease | Neurodevelopmental Disorders | 1.19e-03 | 93 | 146 | 4 | C1535926 | |
| Disease | Myoclonic Astatic Epilepsy | 1.30e-03 | 11 | 146 | 2 | C0393702 | |
| Disease | dimethylglycine measurement | 1.54e-03 | 46 | 146 | 3 | EFO_0010476 | |
| Disease | Pancreatic Neoplasm | 1.56e-03 | 100 | 146 | 4 | C0030297 | |
| Disease | pancreatic cancer (is_marker_for) | 1.62e-03 | 101 | 146 | 4 | DOID:1793 (is_marker_for) | |
| Disease | Primary Ciliary Dyskinesia | 1.64e-03 | 47 | 146 | 3 | C4551720 | |
| Disease | Malignant neoplasm of pancreas | 1.68e-03 | 102 | 146 | 4 | C0346647 | |
| Disease | cannabis dependence measurement | 1.74e-03 | 48 | 146 | 3 | EFO_0008457 | |
| Disease | colitis (implicated_via_orthology) | 1.83e-03 | 13 | 146 | 2 | DOID:0060180 (implicated_via_orthology) | |
| Disease | Epilepsy | 2.14e-03 | 109 | 146 | 4 | C0014544 | |
| Disease | interleukin 1 receptor antagonist measurement | 2.32e-03 | 53 | 146 | 3 | EFO_0004754 | |
| Disease | Sinus Node Dysfunction (disorder) | 2.45e-03 | 15 | 146 | 2 | C0428908 | |
| Disease | Bipolar Disorder | 2.66e-03 | 477 | 146 | 8 | C0005586 | |
| Disease | Neuralgia, Supraorbital | 2.79e-03 | 16 | 146 | 2 | C0038870 | |
| Disease | Tremor, Rubral | 2.79e-03 | 16 | 146 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.79e-03 | 16 | 146 | 2 | C0750937 | |
| Disease | Neuralgia | 2.79e-03 | 16 | 146 | 2 | C0027796 | |
| Disease | Ataxia, Motor | 2.79e-03 | 16 | 146 | 2 | C0278161 | |
| Disease | Romano-Ward Syndrome | 2.79e-03 | 16 | 146 | 2 | C0035828 | |
| Disease | Neuralgia, Atypical | 2.79e-03 | 16 | 146 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 2.79e-03 | 16 | 146 | 2 | C0234249 | |
| Disease | Ataxia, Sensory | 2.79e-03 | 16 | 146 | 2 | C0240991 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 2.79e-03 | 16 | 146 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 2.79e-03 | 16 | 146 | 2 | C0423711 | |
| Disease | Abnormal coordination | 2.79e-03 | 16 | 146 | 2 | C0520966 | |
| Disease | fourth ventricle volume measurement | 2.79e-03 | 16 | 146 | 2 | EFO_0010303 | |
| Disease | Ataxia, Truncal | 2.79e-03 | 16 | 146 | 2 | C0427190 | |
| Disease | Paroxysmal Nerve Pain | 2.79e-03 | 16 | 146 | 2 | C0751373 | |
| Disease | Nerve Pain | 2.79e-03 | 16 | 146 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 2.79e-03 | 16 | 146 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 2.79e-03 | 16 | 146 | 2 | C0042656 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.79e-03 | 16 | 146 | 2 | C0393706 | |
| Disease | free cholesterol in very large VLDL measurement | 3.46e-03 | 61 | 146 | 3 | EFO_0022274 | |
| Disease | alcohol consumption measurement | DOCK1 CACNA1A GABRG1 DPP4 TMEM138 GRM3 DHX15 SCN8A FOXP1 IGSF9B ARHGAP27 HAS3 GABRA2 MYBPC3 | 3.52e-03 | 1242 | 146 | 14 | EFO_0007878 |
| Disease | essential hypertension (is_implicated_in) | 3.53e-03 | 18 | 146 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | phospholipids in large VLDL measurement | 3.63e-03 | 62 | 146 | 3 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 3.63e-03 | 62 | 146 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 3.63e-03 | 62 | 146 | 3 | EFO_0022299 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 3.93e-03 | 19 | 146 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | osteoporosis (implicated_via_orthology) | 3.93e-03 | 19 | 146 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | cholesterol in large VLDL measurement | 4.14e-03 | 65 | 146 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 4.14e-03 | 65 | 146 | 3 | EFO_0022230 | |
| Disease | response to vaccine, cytokine measurement | 4.15e-03 | 131 | 146 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | total lipids in large VLDL | 4.51e-03 | 67 | 146 | 3 | EFO_0022175 | |
| Disease | Grand Mal Status Epilepticus | 4.51e-03 | 67 | 146 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 4.51e-03 | 67 | 146 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 4.51e-03 | 67 | 146 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 4.51e-03 | 67 | 146 | 3 | C0751523 | |
| Disease | Petit mal status | 4.51e-03 | 67 | 146 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 4.51e-03 | 67 | 146 | 3 | C0393734 | |
| Disease | Status Epilepticus | 4.70e-03 | 68 | 146 | 3 | C0038220 | |
| Disease | free cholesterol in large VLDL measurement | 4.70e-03 | 68 | 146 | 3 | EFO_0022265 | |
| Disease | Hirschsprung disease | 4.80e-03 | 21 | 146 | 2 | MONDO_0018309 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLAYVASVWGNFVNM | 26 | Q8NBZ7 | |
| VLLLSYTWAQVDAMF | 606 | Q14146 | |
| VMAFGILNYFRDAWN | 1616 | O00555 | |
| LYLATFFWMLAQALV | 851 | Q8IZF5 | |
| SWTFYIQVMTFNQAE | 276 | P04040 | |
| WMAFSYITNNALLGR | 71 | Q8IZF6 | |
| MAEILRFFNWTYVST | 201 | Q14832 | |
| QWITFQHFSFLKRMY | 46 | Q12887 | |
| VLQRLQMFWSNFASL | 641 | Q96DT5 | |
| QMFWSNFASLRYLFL | 646 | Q96DT5 | |
| MTLQWAAVATFLYAE | 1 | Q9UHQ4 | |
| LLEFSQYLENYLWMN | 66 | O60306 | |
| DSINLDWMFRYSLIN | 611 | P20594 | |
| RFDQFWAINRKLMEY | 161 | Q9H1Y0 | |
| TRWLMQVNFVSYVQL | 131 | Q7Z5J1 | |
| VQWCYDNFINYRSLM | 641 | O43143 | |
| TMIDQWYLIFFNLLF | 1116 | O60312 | |
| NLSTFWISMVDAFYQ | 1191 | O94823 | |
| SMTDYWVLIFFNLLF | 1141 | Q9P241 | |
| YRLVVMEQFASFKWN | 571 | Q9BYT9 | |
| MWYQQGFRSLEDIRS | 351 | Q9UGP5 | |
| SSVYKQQWFAMLRAE | 361 | Q96IK5 | |
| HNFMERLWAYLTIQQ | 541 | Q14624 | |
| ILWALYFNMRDSSDI | 546 | P24386 | |
| WTLFQHTLQNEYELM | 681 | P06400 | |
| MFDITKQWTFNYILR | 146 | Q3YEC7 | |
| FMLNWRENEYLTLQV | 666 | Q75QN2 | |
| MNNFRATILFWAAAA | 1 | Q2M385 | |
| SYSLQVTFALNWMIR | 1231 | O15438 | |
| FFAWRFVTALYMTDI | 61 | Q9NXK6 | |
| WRFNLLVFTMVYTVT | 86 | P48544 | |
| NFTITNLRYEENMWP | 13796 | Q8WXI7 | |
| EMNTLFRFWSFFLRD | 911 | Q6PKG0 | |
| FIYSLRNWDMKAALQ | 286 | Q9Y585 | |
| DSIAYWNATRAFMIL | 56 | P55344 | |
| IFIARSQMARNIWYF | 481 | Q8WVX9 | |
| SQMARNIWYFVVSLC | 486 | Q8WVX9 | |
| FWAIIMYNLVSLNSL | 436 | Q9HCP6 | |
| QQMAIDWLTRNLYFV | 286 | Q9NZR2 | |
| AYMATQFGILARLTW | 241 | Q8NE86 | |
| FWMFHSQAVYDINRL | 101 | Q6L9T8 | |
| VLFVFWNLLDMVRYT | 116 | Q5VWC8 | |
| FIMHNNDLTWNLFTY | 376 | O95671 | |
| VTALSFTMLRAQYWF | 991 | P54707 | |
| VWYSIFMASDDLNRI | 36 | Q8WX39 | |
| LMVAALAYNQWFTKL | 206 | Q8ND23 | |
| NIYNMQFLLFVFLVW | 6 | P47869 | |
| VFNALNYWLTMFRIR | 391 | P51798 | |
| FSNTSESFVLNWYRM | 56 | Q15116 | |
| VAEKMLTNWFTFLLY | 1436 | Q9UIW2 | |
| LYRQWTDRIMAEFFQ | 601 | P27815 | |
| LYRQWTDRIMAEFFQ | 556 | Q08493 | |
| TFYDDQRQNWSIMFE | 141 | Q5T1M5 | |
| LTLNEIYNWFTRMFA | 486 | Q9H334 | |
| SYLVFWTVSNLMAFL | 186 | Q9UBY5 | |
| MRLSQETQQYFTIWI | 451 | O00522 | |
| FIILNETKFWYQMIL | 516 | P27487 | |
| MLLFLWIETSSEYFN | 1 | Q6W3E5 | |
| RQLTLNEIYNWFTRM | 486 | Q8IVH2 | |
| WDMMYVTRFASFLRN | 231 | O60774 | |
| GWRSFTNVNSRMLYF | 751 | P10275 | |
| FWMFHSQAVYDINRL | 101 | Q5TYM5 | |
| FMYWLSSNLFSLVQV | 316 | Q15070 | |
| QTTFWLRAYFSQPMV | 1081 | Q13219 | |
| NWKAFTFVLSRAYLM | 376 | Q6ZWE6 | |
| WVSQYRFCQLMIENL | 171 | Q8TAG9 | |
| ASFRAVLEMWLSYLQ | 431 | Q9NXE4 | |
| FREYHERLQTFLMWF | 171 | O14929 | |
| TIWRQLYVQDNREMF | 101 | Q14185 | |
| RESALQQAWFFFELM | 1001 | Q96N67 | |
| YEFNESDLRISMWQI | 3696 | Q8TD57 | |
| NMEYTIDIIFAQTWF | 106 | Q8N1C3 | |
| WRLYQFDFMGLRNTT | 216 | Q99928 | |
| NVNFQYISLRLTMVW | 131 | Q53EU6 | |
| NWLMYSINGAEIIFN | 241 | Q9UBR1 | |
| SYMTVDNFQRGIFVW | 626 | Q7Z7M9 | |
| NLLAHMNYSFWIEAV | 401 | P29322 | |
| FWMFHSQAVYDINRL | 101 | H0Y354 | |
| YRQMALLSSAFAFGW | 596 | Q6TDU7 | |
| FRFMQTDPNWANFLY | 361 | Q96D53 | |
| VNFYADWCRFSQMLH | 51 | Q9BS26 | |
| RTMSALWNLQYCEFD | 456 | P15586 | |
| FVIMFTLVDENQSWY | 226 | Q6MZM0 | |
| SDFALSNRYMQVWFS | 761 | P49641 | |
| LSRFVAWMNGLSVYQ | 2946 | Q14204 | |
| SFLSSVRYWMAFNVE | 256 | O00219 | |
| FYRQLVANLELMANW | 731 | Q9NYC9 | |
| WMIYFRQFSQLSPAE | 886 | Q8TDG4 | |
| YCMFTQRSFLSEVWN | 621 | Q6SJ93 | |
| SLGNWMVYFLRRFSQ | 4296 | Q8IVF4 | |
| SFFVVFQAWSLMILQ | 161 | P0C7U9 | |
| IWFTANLDTLMTYVQ | 126 | Q8N0W4 | |
| QQVYLALFWLAMSST | 286 | P21452 | |
| FWMFHSQAVYDINRL | 101 | Q86X60 | |
| LYWNMAVRDFSILIN | 1266 | Q9BXW9 | |
| SQEMNTLFRFWSFFL | 731 | Q659C4 | |
| MAQLYFLTWAASSEL | 116 | Q8NGR1 | |
| QQQHIFFLLFLWMYV | 36 | Q8NH06 | |
| VMLFLWYATVFNSAL | 61 | P59542 | |
| TITFEQYMQAGLWFT | 1571 | Q9C093 | |
| GFQLQYQMIFSIWLL | 236 | Q9UI12 | |
| NVVNSWIIFYMSQSF | 201 | Q9GZN6 | |
| TFSWAFLALFRLMTQ | 391 | P35499 | |
| FLALFRLMTQDYWEN | 396 | P35499 | |
| RLMTQDYWENLFQLT | 401 | P35499 | |
| NPFRAYMNLDIWTTT | 1576 | A2VDJ0 | |
| DFNWRFIFTMDYLAA | 1776 | A0AVI2 | |
| LDWMLNQDFTTAYRN | 251 | P40937 | |
| SSVYKQQWFAMLRAE | 361 | Q8NEA9 | |
| FLQVNMYSSVFFLTW | 136 | Q99527 | |
| FFLTWMSFDRYIALA | 146 | Q99527 | |
| MLYTNHFTQEQWVRL | 406 | Q6ZUM4 | |
| TFSWAFLALFRLMTQ | 346 | Q15858 | |
| FLALFRLMTQDYWEN | 351 | Q15858 | |
| SEAEVQSWMRYNIFL | 161 | Q5VSL9 | |
| LFSNWAITADILMYV | 436 | Q8IVW8 | |
| EYERRFQMTFQFSIW | 716 | Q5C9Z4 | |
| MFLHSVNLWNLAFYV | 1 | Q75T13 | |
| VNLWNLAFYVFMVFL | 6 | Q75T13 | |
| LFRLMTQDYWENLYQ | 376 | Q9NY46 | |
| EVSQLWSVLYFFMLL | 386 | Q9NP91 | |
| LLPWNFFMTATQYFT | 26 | Q99808 | |
| YVNWRFMRGIEAQFL | 591 | Q9HCE7 | |
| SSTLWALFVVNLYMF | 471 | Q7Z7B1 | |
| FRLMTQDFWENLYQL | 376 | P35498 | |
| FWAMDTSLQHRYQQL | 361 | Q9C0B6 | |
| QDILMWNYRDTFFNL | 206 | Q9NY97 | |
| MATILSFNRNWRAFD | 286 | C9JRZ8 | |
| WRMLTYKALNTFIDD | 541 | O96005 | |
| EYWLNDMYLNNRLAL | 196 | P28329 | |
| QLWYFMLQYLQTAQS | 211 | Q92759 | |
| MNYSSFLRIWVSFIF | 1 | O75443 | |
| SWINRERFQNYLAMD | 221 | Q96JJ7 | |
| FYQDSLWLRKEFMQV | 146 | Q9NPI0 | |
| LINWTVMILYNYFNA | 61 | Q9H6R6 | |
| RFMRRFNELQYWVAT | 706 | O95398 | |
| ERDTYMLLLWVQNLY | 271 | Q03169 | |
| LLAFQLTFMDANHYW | 166 | P38435 | |
| QYLQSNMRWDFSFAI | 101 | Q6ZUT4 | |
| LWLMERSNDYFVLQR | 16 | Q0IIM8 | |
| LSQDTWYEFRVLAVM | 676 | Q9UPX0 | |
| SFAWAFLSLFRLMTQ | 341 | Q9Y5Y9 | |
| WTAQPDTFAYFQLRM | 981 | P22105 | |
| LFPSTSYNARLQAMW | 3991 | P22105 | |
| SWAFLSLFRLMTQDF | 371 | Q99250 | |
| SLFRLMTQDFWENLY | 376 | Q99250 | |
| MTQDFWENLYQLTLR | 381 | Q99250 | |
| SQEMTNILYWINLVF | 1556 | Q99250 | |
| IASMWILFGAYVTQN | 111 | P56557 | |
| FSWAFLALFRLMTQD | 356 | Q9UQD0 | |
| LALFRLMTQDYWENL | 361 | Q9UQD0 | |
| NYQTASFLIALVWMV | 166 | Q8NFJ6 | |
| EVRYLQFAFRWMNNL | 411 | Q8WUA7 | |
| LISFAWQISQGMQYL | 851 | P07949 | |
| SLQMSIALYWINSIF | 1276 | Q01118 | |
| RCFYFTIAWNIFDFM | 1306 | Q01118 | |
| FILFSWVLNMFITNN | 136 | Q8TDU5 | |
| FQLSMWIRTCHNYFI | 156 | Q9H3N1 | |
| YLFMIIWQLTELNTF | 291 | P48651 | |
| NATDYWTFRKMFTIQ | 3661 | Q9Y4A5 | |
| FYWMSVQTIRNVFSV | 36 | O95922 | |
| ECRSLDFQATTMFWY | 36 | A0A075B6N2 | |
| YRWMRLNFDLIQELS | 816 | Q14896 |